{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:37:11Z","timestamp":1785854231205,"version":"3.56.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MSD"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Karyopharm"},{"DOI":"10.13039\/501100008001","name":"University of Cologne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DMyKG"},{"DOI":"10.13039\/100009139","name":"DZIF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100016300","name":"Octapharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016300","id-type":"DOI","asserted-by":"crossref"}]},{"name":"GILEAD"},{"name":"MSD SHARP & DOHME"},{"name":"The German Federal Ministry of Health"},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MSD"},{"name":"NewConceptOncology"},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Neovii"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janssen"},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Takeda"},{"name":"German Federal Ministry of Research and Education"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Actelion"},{"name":"Amplyx"},{"name":"Astellas"},{"name":"Basilea"},{"DOI":"10.13039\/100010643","name":"Cidara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010643","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Da Volterra"},{"name":"F2G"},{"name":"Gilead"},{"name":"Janssen"},{"name":"Melinta"},{"name":"Merck"},{"DOI":"10.13039\/501100016300","name":"Octapharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016300","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scynexis"},{"name":"Actelion"},{"name":"Allecra"},{"name":"Amplyx"},{"name":"Astellas"},{"name":"Basilea"},{"name":"Biosys"},{"DOI":"10.13039\/100010643","name":"Cidara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010643","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Da Volterra"},{"name":"Entasis"},{"name":"F2G"},{"name":"Gilead"},{"name":"IQVIA"},{"name":"Matinas"},{"DOI":"10.13039\/100007050","name":"MedPace","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Menarini"},{"name":"Merck"},{"DOI":"10.13039\/100016259","name":"Mylan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016259","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nabriva"},{"name":"Noxxon"},{"DOI":"10.13039\/501100016300","name":"Octapharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016300","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Paratek"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PSI"},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scynexis"},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Astellas"},{"name":"Basilea"},{"name":"Gilead"},{"name":"Grupo Biotoscana"},{"name":"Merck"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Miltenyi Biotec GmbH"},{"name":"Bergisch Gladbach"},{"DOI":"10.13039\/501100008001","name":"University of Cologne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008001","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gilead"},{"DOI":"10.13039\/100010795","name":"Chugai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janssen"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Takeda"},{"name":"BMS"},{"DOI":"10.13039\/501100014841","name":"Medac","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Oncopeptides"},{"name":"Merck"},{"name":"CDDF"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"DPharma"},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BMBF"},{"name":"Deutsche Jose Carreras Leuk\u00e4mie-Stiftung"},{"name":"IZKF Jena"},{"name":"DFG"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gilead"},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ejca.2020.09.009","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T15:45:00Z","timestamp":1600703100000},"page":"86-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-2564","authenticated-orcid":false,"given":"Nicola","family":"Giesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-6437","authenticated-orcid":false,"given":"Rosanne","family":"Sprute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"R\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yascha","family":"Khodamoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle C.","family":"Mellinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Beutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9597-6142","authenticated-orcid":false,"given":"Catherina","family":"Lueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Koldehoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hentrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sandherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Heinrich","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"W\u00f6rmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-3137","authenticated-orcid":false,"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-7495","authenticated-orcid":false,"given":"Philipp","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Schalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"von Lilienfeld-Toal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.ejca.2020.09.009_bib1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ejca.2020.09.009_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study","volume":"71","author":"Giacomelli","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10223","key":"10.1016\/j.ejca.2020.09.009_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 silent hypoxemia is baffling to physicians","volume":"202","author":"Tobin","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejca.2020.09.009_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fimmu.2020.01022","article-title":"Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-cov-2 infection","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejca.2020.09.009_bib9","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3389\/fimmu.2020.01841","article-title":"Mechanisms underlying potential therapeutic approaches for COVID-19","volume":"11","author":"Benani","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib14","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1111\/bjh.16874","article-title":"Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy","volume":"190","author":"Cook","year":"2020","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib15","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41375-020-0925-7","article-title":"Impact of Covid-19 on the treatment of acute myeloid leukemia","volume":"34","author":"Ferrara","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2020.09.009_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.3460","article-title":"Covid-19 in patients with solid and hematological cancers at a Comprehensive Cancer Center in Germany","author":"Shoumariyeh","year":"2020","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.ejca.2020.09.009_bib17","article-title":"Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany","author":"Engelhardt","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10549-020-05667-6","article-title":"Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City","volume":"182","author":"Kalinsky","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000508272","article-title":"Implications of SARS-CoV-2 infection and COVID-19 crisis on clinical cancer care: report of the university cancer center hamburg","volume":"43","author":"Weisel","year":"2020","journal-title":"Oncol Res Treat"},{"issue":"10241","key":"10.1016\/j.ejca.2020.09.009_bib20","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41591-020-0874-8","article-title":"Caring for patients with cancer in the COVID-19 era","volume":"26","author":"van de Haar","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-020-0919-0","article-title":"The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy","author":"Ljungman","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 7","key":"10.1016\/j.ejca.2020.09.009_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejca.2020.09.009_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejca.2016.08.015","article-title":"Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology","volume":"67","author":"von Lilienfeld-Toal","year":"2016","journal-title":"Eur J Cancer"},{"issue":"10229","key":"10.1016\/j.ejca.2020.09.009_bib26","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ejca.2020.09.009_bib27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.annonc.2020.03.297","article-title":"COVID-19 infection in cancer patients: early observations and unanswered questions","volume":"31","author":"Oh","year":"2020","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib30","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/bjh.16801","article-title":"Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies","volume":"190","author":"Mart\u00edn-Moro","year":"2020","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case fatality rate of cancer patients with COVID-19 in a New York hospital system","volume":"10","author":"Mehta","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejca.2020.09.009_bib32","first-page":"1","article-title":"Reply to \"COVID-19 in persons with haematological cancers\": a focus on myeloid neoplasms and risk factors for mortality","author":"Fattizzo","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib33","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/bjh.16852","article-title":"Clinical outcome of coronavirus disease 2019 in haemato-oncology patients","volume":"190","author":"Aries","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2020.09.009_bib34","series-title":"A systematic review and meta-analysis of cancer patients affected by a novel coronavirus","author":"Venkatesulu","year":"2020"},{"issue":"7821","key":"10.1016\/j.ejca.2020.09.009_bib35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib36","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1111\/bjh.16935","article-title":"Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King\u2019s College Hospital experience","volume":"190","author":"Shah","year":"2020","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(20)30311-9","article-title":"Poor clinical outcomes for patients with cancer during the COVID-19 pandemic","volume":"21","author":"Tang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib39","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","article-title":"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","volume":"21","author":"Yang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10241","key":"10.1016\/j.ejca.2020.09.009_bib40","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2020.09.009_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25972","article-title":"Clinical characteristics and outcomes of cancer patients with COVID-19","author":"Yang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ejca.2020.09.009_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejca.2020.05.028","article-title":"High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR","volume":"135","author":"Assaad","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.09.009_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejca.2020.06.001","article-title":"SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death","volume":"135","author":"Yarza","year":"2020","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib44","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1002\/ajh.25870","article-title":"Granulocyte-colony stimulating factor in COVID-19: is it stimulating more than just the bone marrow?","volume":"95","author":"Nawar","year":"2020","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib45","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2468-2667(20)30090-6","article-title":"Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study","volume":"5","author":"Cowling","year":"2020","journal-title":"Lancet Publ Health"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib46","doi-asserted-by":"crossref","DOI":"10.3201\/eid2608.201093","article-title":"Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of coronavirus disease","volume":"26","author":"Matrajt","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ejca.2020.09.009_bib47","doi-asserted-by":"crossref","first-page":"m1923","DOI":"10.1136\/bmj.m1923","article-title":"Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study","volume":"369","author":"Lewnard","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib48","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/S2468-2667(20)30073-6","article-title":"The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study","volume":"5","author":"Prem","year":"2020","journal-title":"Lancet Publ Health"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinf.2020.04.024","article-title":"The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2","volume":"81","author":"Cheng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ejca.2020.09.009_bib50","doi-asserted-by":"crossref","first-page":"105585","DOI":"10.1016\/j.jaerosci.2020.105585","article-title":"Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: a numerical study","author":"Feng","year":"2020","journal-title":"J Aerosol Sci"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/jmv.23222","article-title":"Single treatment with ethanol hand rub is ineffective against human rhinovirus--hand washing with soap and water removes the virus efficiently","volume":"84","author":"Savolainen-Kopra","year":"2012","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/595845","article-title":"Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers","volume":"48","author":"Grayson","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib53","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3201\/eid2607.200915","article-title":"Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols","volume":"26","author":"Kratzel","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"10.1016\/j.ejca.2020.09.009_bib54","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajic.2020.05.027","article-title":"Environmental contamination of SARS-CoV-2 during the COVID-19 outbreak in South Korea","volume":"48","author":"Ryu","year":"2020","journal-title":"Am J Infect Contr"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhin.2020.01.022","article-title":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents","volume":"104","author":"Kampf","year":"2020","journal-title":"J Hosp Infect"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib57","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41591-020-0843-2","article-title":"Respiratory virus shedding in exhaled breath and efficacy of face masks","volume":"26","author":"Leung","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib58","article-title":"Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ejca.2020.09.009_bib59","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/cid\/cix681","article-title":"Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis","volume":"65","author":"Offeddu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.009_bib60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/irv.12745","article-title":"Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: a systematic review and meta-analysis of randomized trials","volume":"14","author":"Bartoszko","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1750-2659.2011.00198.x","article-title":"A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers","volume":"5","author":"MacIntyre","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ejca.2020.09.009_bib62","unstructured":"Yan Y, Chen H, Chen L, Cheng B, Diao P, Dong L, et\u00a0al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatol Ther. 2020:e13310."},{"issue":"10242","key":"10.1016\/j.ejca.2020.09.009_bib63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jemermed.2020.04.060","article-title":"The ocular manifestations and transmission of COVID-19: recommendations for prevention","volume":"59","author":"Dockery","year":"2020","journal-title":"J Emerg Med"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018782","article-title":"Effect of isolation practice on the transmission of middle east respiratory syndrome coronavirus among hemodialysis patients: a 2-year prospective cohort study","volume":"99","author":"Park","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"He","year":"2020","journal-title":"Nat Med"},{"issue":"7809","key":"10.1016\/j.ejca.2020.09.009_bib67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/infdis\/jiaa311","article-title":"Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study","volume":"222","author":"Hao","year":"2020","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib69","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.eururo.2020.03.039","article-title":"Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in wuhan, China","volume":"77","author":"Zhu","year":"2020","journal-title":"Eur Urol"},{"issue":"15","key":"10.1016\/j.ejca.2020.09.009_bib70","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/cid\/ciaa351","article-title":"Factors associated with prolonged viral RNA shedding in patients with COVID-19","volume":"71","author":"Xu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejca.2020.09.009_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa301","article-title":"The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan, China","author":"Zou","year":"2020","journal-title":"J Infect Dis"},{"issue":"25","key":"10.1016\/j.ejca.2020.09.009_bib72","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ejca.2020.09.009_bib73","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"issue":"10238","key":"10.1016\/j.ejca.2020.09.009_bib74","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.009_bib75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.dsx.2020.04.050","article-title":"Vitamin D concentrations and COVID-19 infection in UK Biobank","volume":"14","author":"Hastie","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12890-018-0677-6","article-title":"Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis","volume":"18","author":"Wu","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib77","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","article-title":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19","volume":"81","author":"Xie","year":"2020","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.ejca.2020.09.009_bib78","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/annonc\/mdu035","volume":"25","author":"Vehreschild","year":"2014","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.009_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials","volume":"324","author":"Xia","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"10240","key":"10.1016\/j.ejca.2020.09.009_bib80","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"issue":"10249","key":"10.1016\/j.ejca.2020.09.009_bib81","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib82","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/annonc\/mdy117","article-title":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)","volume":"29","author":"Rieger","year":"2018","journal-title":"Ann Oncol"},{"issue":"20","key":"10.1016\/j.ejca.2020.09.009_bib83","first-page":"30120","article-title":"Effective strategies to prevent in-hospital infection in the emergency department during the novel coronavirus disease 2019 pandemic","volume":"S1684-1182","author":"Kung","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib84","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/bjh.16818","article-title":"Successful prevention and screening strategies for COVID-19: focus on patients with haematologic diseases","volume":"190","author":"Cho","year":"2020","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.ejca.2020.09.009_bib85","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility","volume":"382","author":"Arons","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejca.2020.09.009_bib86","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"21","key":"10.1016\/j.ejca.2020.09.009_bib87","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.2020006028","article-title":"ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic","volume":"135","author":"Yahalom","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.009_bib88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5694\/mja2.50607","article-title":"Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance","volume":"212","author":"Weinkove","year":"2020","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1213\/ANE.0000000000004844","article-title":"Essential role of patient blood management in a pandemic: a call for action","volume":"131","author":"Shander","year":"2020","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib90","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41571-020-0370-6","article-title":"Provision of cancer care during the COVID-19 pandemic","volume":"17","author":"Spicer","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2020.09.009_bib91","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2020.06.019","article-title":"Impact of the COVID-19 pandemic on cancer treatment: the patients\u2019 perspective","volume":"136","author":"de Joode","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.09.009_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejca.2020.04.034","article-title":"Cancer treatment during the coronavirus disease 2019 pandemic: do not postpone, do it!","volume":"133","author":"Omarini","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib93","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/bjh.16758","article-title":"Philadelphia-positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID-19 pandemic: a Campus ALL study","volume":"190","author":"Foa","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-020-01293-8","article-title":"COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area","volume":"22","author":"Vuagnat","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"10243","key":"10.1016\/j.ejca.2020.09.009_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)31182-X","article-title":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study","volume":"396","author":"Collaborative","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.009_bib96","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12282-018-0848-6","article-title":"Cyclin-dependent kinase 4\/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials","volume":"25","author":"Ramos-Esquivel","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejca.2020.09.009_bib97","article-title":"Dexamethasone in hospitalized patients with covid-19 - preliminary report","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib98","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib99","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/2159-8290.CD-20-0596","article-title":"Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers","volume":"10","author":"Luo","year":"2020","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.ejca.2020.09.009_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","article-title":"COVID-19 in patients with lung cancer","volume":"31","author":"Luo","year":"2020","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib101","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/bjh.16863","article-title":"Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19","volume":"190","author":"Thibaud","year":"2020","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.ejca.2020.09.009_bib102","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib103","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaci.2020.05.019","article-title":"Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial","volume":"146","author":"Cao","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib104","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41375-020-0853-6","article-title":"COVID-19 in persons with chronic myeloid leukaemia","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.16896","article-title":"Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature","volume":"190","author":"Tepasse","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2020.09.009_bib106","article-title":"Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab","author":"Fallet","year":"2020","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib107","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/bjh.16787","article-title":"Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma","volume":"190","author":"Chaidos","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2020.09.009_bib108","series-title":"Multiple myeloma and COVID-19. Leukemia","author":"Dhakal","year":"2020"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib109","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1378\/chest.06-1734","article-title":"Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide","volume":"131","author":"Thornburg","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ejca.2020.09.009_bib110","article-title":"Posterior oropharyngeal saliva for the detection of SARS-CoV-2","author":"Cheuk","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.ejca.2020.09.009_bib111","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib112","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/jiaa464","article-title":"Epidemiology of SARS-CoV-2 emergence amidst community-acquired respiratory viruses","volume":"222","author":"Leuzinger","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejca.2020.09.009_bib113","article-title":"Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs","author":"Wyllie","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ejca.2020.09.009_bib114","article-title":"Antibody detection and dynamic characteristics in patients with COVID-19","author":"Xiang","year":"2020","journal-title":"Clinical Infect Dis"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib116","article-title":"Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ejca.2020.09.009_bib117","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1148\/radiol.2020200432","article-title":"Sensitivity of chest CT for COVID-19: comparison to RT-PCR","volume":"296","author":"Fang","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2020.09.009_bib118","first-page":"200642","article-title":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases","author":"Ai","year":"2020","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.009_bib119","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ejca.2020.09.009_bib120","series-title":"WHO R&D blueprint novel coronavirus COVID-19 therapeutic trial synopsis","year":"2020"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib121","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fpubh.2020.00249","article-title":"Effectiveness of arbidol for COVID-19 prevention in health professionals","volume":"8","author":"Yang","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.ejca.2020.09.009_bib123","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - preliminary report","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib124","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 Days in patients with severe covid-19","author":"Goldman","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib125","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.ejca.2020.09.009_bib126","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib127","series-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (Beijing)","author":"Cai","year":"2020"},{"key":"10.1016\/j.ejca.2020.09.009_bib128","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.AC120.013788","article-title":"Inhibition of SARS-CoV-2 by type I and type III interferons","author":"Felgenhauer","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2020.09.009_bib129","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon-alpha2b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib130","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ejca.2020.09.009_bib131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study","volume":"76","author":"Campochiaro","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib132","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/qjmed\/hcaa206","article-title":"Outcomes in patients with severe COVID-19 disease treated with tocilizumab - a case- controlled study","volume":"113","author":"Rojas-Marte","year":"2020","journal-title":"QJM"},{"issue":"20","key":"10.1016\/j.ejca.2020.09.009_bib133","first-page":"31670","article-title":"Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes","volume":"S0012-3692","author":"Price","year":"2020","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ejca.2020.09.009_bib134","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ejca.2020.09.009_bib135","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","author":"Somers","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejca.2020.09.009_bib136","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.ejca.2020.09.009_bib137","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jinf.2020.06.052","article-title":"Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia","volume":"81","author":"Cantini","year":"2020","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib138","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Rosee","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib139","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","volume":"324","author":"Li","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2020.09.009_bib140","article-title":"The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study","author":"Duan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ejca.2020.09.009_bib141","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5,000 patients","author":"Joyner","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ejca.2020.09.009_bib142","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib143","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib144","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.09.009_bib146","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13045-020-00907-0","article-title":"Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis","volume":"13","author":"Meng","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2020.09.009_bib147","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib148","doi-asserted-by":"crossref","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","article-title":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019","volume":"7","author":"Cao","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.ejca.2020.09.009_bib149","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/joim.12767","article-title":"Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia","volume":"284","author":"Bekele","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejca.2020.09.009_bib150","doi-asserted-by":"crossref","first-page":"104437","DOI":"10.1016\/j.jcv.2020.104437","article-title":"SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients","volume":"128","author":"Korth","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ejca.2020.09.009_bib151","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.2548","article-title":"Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates","author":"Al-Shamsi","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2020.09.009_bib152","first-page":"1","article-title":"Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe","author":"Cinar","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2020.09.009_bib153","first-page":"1","article-title":"Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal","author":"Ueda","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.ejca.2020.09.009_bib155","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2020.09.009_bib156","series-title":"WHO R&D blueprint novel coronavirus COVID-19 therapeutic trial synopsis","year":"2020"},{"key":"10.1016\/j.ejca.2020.09.009_bib157","article-title":"Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma","author":"Salazar","year":"2020","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.ejca.2020.09.009_bib158","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2 Suppl","key":"10.1016\/j.ejca.2020.09.009_bib159","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ejca.2020.09.009_bib160","article-title":"Extracorporeal life support organization COVID-19 interim guidelines","author":"Shekar","year":"2020","journal-title":"ASAIO J"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920304937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920304937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:30:02Z","timestamp":1760733002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920304937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":158,"alternative-id":["S0959804920304937"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}